Swee‐Peng Yap

683 total citations
9 papers, 532 citations indexed

About

Swee‐Peng Yap is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Swee‐Peng Yap has authored 9 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Swee‐Peng Yap's work include Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Swee‐Peng Yap is often cited by papers focused on Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Swee‐Peng Yap collaborates with scholars based in Singapore. Swee‐Peng Yap's co-authors include Eng-Huat Tan, Kam-Weng Fong, Philip Eng, Wan‐Teck Lim, Swan‐Swan Leong, Thirugnanam Agasthian, Chee‐Keong Toh, Heng‐Nung Koong, Anne Ann Ling Hsu and Fei Gao and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Swee‐Peng Yap

9 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Swee‐Peng Yap Singapore 7 287 255 100 98 80 9 532
Esra Kaytan Türkiye 10 240 0.8× 189 0.7× 46 0.5× 115 1.2× 34 0.4× 18 480
M. Marcy France 14 160 0.6× 174 0.7× 105 1.1× 52 0.5× 78 1.0× 24 508
Virag Dandekar United States 4 234 0.8× 151 0.6× 109 1.1× 24 0.2× 48 0.6× 6 527
Haruhito Kamei Japan 9 389 1.4× 465 1.8× 53 0.5× 37 0.4× 53 0.7× 37 573
Chihiro Kondoh Japan 13 302 1.1× 241 0.9× 109 1.1× 64 0.7× 20 0.3× 49 546
Sehhoon Park South Korea 14 291 1.0× 124 0.5× 96 1.0× 30 0.3× 157 2.0× 53 499
B.G. Taal Netherlands 12 216 0.8× 134 0.5× 34 0.3× 152 1.6× 247 3.1× 21 538
A. Chemaissani Germany 9 464 1.6× 508 2.0× 124 1.2× 35 0.4× 18 0.2× 13 650
Ji Hyeon Joo South Korea 13 125 0.4× 151 0.6× 24 0.2× 65 0.7× 53 0.7× 53 463
Patrick M. Travis United States 8 233 0.8× 352 1.4× 23 0.2× 52 0.5× 25 0.3× 10 482

Countries citing papers authored by Swee‐Peng Yap

Since Specialization
Citations

This map shows the geographic impact of Swee‐Peng Yap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swee‐Peng Yap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swee‐Peng Yap more than expected).

Fields of papers citing papers by Swee‐Peng Yap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swee‐Peng Yap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swee‐Peng Yap. The network helps show where Swee‐Peng Yap may publish in the future.

Co-authorship network of co-authors of Swee‐Peng Yap

This figure shows the co-authorship network connecting the top 25 collaborators of Swee‐Peng Yap. A scholar is included among the top collaborators of Swee‐Peng Yap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swee‐Peng Yap. Swee‐Peng Yap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Yap, Swee‐Peng, Wan‐Teck Lim, Siew Wan Hee, et al.. (2008). Induction Concurrent Chemoradiotherapy Using Paclitaxel and CarboplatinCombination Followed by Surgery in Locoregionally Advanced Non-Small Cell Lung Cancer – Asian Experience. Annals of the Academy of Medicine Singapore. 37(5). 377–382. 7 indexed citations
2.
Hee, Siew Wan, L C Lim, Miriam Tao, et al.. (2008). Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab. Leukemia & lymphoma. 49(3). 462–469. 76 indexed citations
3.
Lim, Soon Thye, et al.. (2007). The relationship of hepatitis B virus infection and non‐Hodgkin’s lymphoma and its impact on clinical characteristics and prognosis. European Journal Of Haematology. 79(2). 132–137. 68 indexed citations
4.
Toh, Chee‐Keong, Siew Wan Hee, Wan‐Teck Lim, et al.. (2007). Survival of Small-cell Lung Cancer and its Determinants of Outcome in Singapore. Annals of the Academy of Medicine Singapore. 36(3). 181–188. 6 indexed citations
5.
Toh, Chee‐Keong, Fei Gao, Wan‐Teck Lim, et al.. (2007). Differences between small-cell lung cancer and non-small-cell lung cancer among tobacco smokers. Lung Cancer. 56(2). 161–166. 22 indexed citations
6.
Toh, Chee‐Keong, Fei Gao, Wan‐Teck Lim, et al.. (2006). Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity. Journal of Clinical Oncology. 24(15). 2245–2251. 301 indexed citations
7.
Poon, Donald, et al.. (2004). Induction chemotherapy followed by radiotherapy in Merkel-cell carcinoma. The Lancet Oncology. 5(8). 509–510. 4 indexed citations
8.
Poon, Donald, Swee‐Peng Yap, Yin‐Bun Cheung, et al.. (2004). Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma. International Journal of Radiation Oncology*Biology*Physics. 59(5). 1312–1318. 33 indexed citations
9.
Yap, Swee‐Peng, et al.. (2002). Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinoma. Head & Neck. 24(6). 549–554. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026